Management of hyperhaemolysis after a transfusion in sickle‐cell patients

E-ISSN： 1751-2824|11|S1|196-200

ISSN： 1751-2816

Source： ISBT SCIENCE SERIES, Vol.11, Iss.S1, 2016-01, pp. : 196-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: retrospective study

By Ould amar A.K. Delattre O. Godbille C. Bera O. Halbout P.A. Catonne Y.

Transfusion Clinique et Biologique, Vol. 10, Iss. 2, 2003-04 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin and Intravenous Methylprednisolone in Hyperhaemolysis Syndrome in Sickle Cell Disease

By Win Nay Yeghen Tullie Needs Malcolm Chen Frederick E. Okpala Iheanyi

Hematology, Vol. 9, Iss. 5-6, 2004-10 ,pp. : 433-436

Maney Publishing

Access to resources Recommend Favorite

Viral seroprevalence, transfusion and alloimmunization in adult sickle cell patients in Guadeloupe.

By Le Turdu-Chicot C. Foucan L. Etienne-Julan-Otto M.

Transfusion Clinique et Biologique, Vol. 9, Iss. 2, 2002-04 ,pp. : 115-120

Elsevier

Access to resources Recommend Favorite

Transfusion therapy for sickle cell disease

ISBT SCIENCE SERIES, Vol. 11, Iss. S1, 2016-01 ,pp. : 263-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sickle-cell anemia and pulmonary hypertension

By Ninkovich Glenda M. Miller Sally K. Alpert Patricia T.

Journal of the American Academy of Nurse Practitioners, Vol. 22, Iss. 4, 2010-04 ,pp. : 198-204

Blackwell Publishing

Access to resources Recommend Favorite